DMIIR · Drugs Made In America Acquisition II Corp. · Exempt Offerings
$0.07
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 14, 2026
Market Cap
$649.42M
Shares
63.70M
Volume · Oct 27
18.2K
Avg daily vol (3M)
24.86K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
2040475
CUSIP
G2851K104
13F (30d)
1 filings
1 filers